Effective December 5, 2018, Stephen M. Hewitt, MD, PhD, joined The FASEB Journal's prestigious roster of associate editors (AEs). In this role, he manages the peer review and submission decision processes on manuscripts in his area of expertise and will collaborate with the journal’s current group of AEs.
“I am delighted for the opportunity to serve as an associate editor of The FASEB Journal. The value of journals that focus on cross-discipline basic and translational science cannot be overestimated. As an editor, the creativity and impact of cross-discipline manuscripts makes the task challenging and rewarding,” said Dr. Hewitt, regarding his new appointment.
Dr. Hewitt is a Captain in the U.S. Public Health Service, serving as a Medical Officer within the Laboratory of Pathology, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, in Bethesda, Maryland. He has served as head of the Experimental Pathology Laboratory, as well as the Tissue Qualification and Extraction Laboratory, having previously led the Tissue Array Research Program and the Applied Molecular Pathology Laboratory. Hewitt's research interests are in the development of tissue-based biomarkers for cancer. His interests extend across a diversity of cancer types, with a focus on drug targets and prognostic and predictive factors, as well as immuno-oncology.
He received his bachelor's degree in philosophy from the Johns Hopkins University, and his PhD in genetics from the University of Texas, Graduate School of Biomedical Sciences, having completed his thesis at the University of Texas M.D. Anderson Cancer Center. He completed his MD at the University of Texas Medical School at Houston, and his residency in Anatomic Pathology within the Laboratory of Pathology at the National Cancer Institute. He is a board-certified Anatomic Pathologist and Fellow of the College of American Pathologists, and a member of two FASEB societies: the Histochemical Society and the American Society for Investigative Pathology.
“For some time now I have felt a need for Associate Editor coverage of oncology, both as basic and translational research, to give such manuscripts the high level of attention they warrant and to also signal authors in this field that the welcome sign is on our door,” said Thoru Pederson, PhD, editor-in-chief, The FASEB Journal. “Stephen Hewitt fulfills this need perfectly, given his breadth in cancer research, as well as his overall editorial experience.”
Dr. Hewitt joins The FASEB Journal’s roster of associate editors: Robert Goldman, PhD, Northwestern University; Laura Goldsmith, PhD, Rutgers New Jersey Medical School; Elizabeth Jonas, MD, Yale School of Medicine; C. Ronald Kahn, MD, Harvard Medical School; Charles N. Serhan, PhD, DSc, Brigham and Women's Hospital, Harvard Institutes of Medicine; Babette Weksler, MD, Weill Cornell Medical College; and Richard D. Ye, PhD, University of Macau; as well as editor-in-chief, Dr. Pederson, University of Massachusetts Medical School. Biographical sketches for each editor can be found on The FASEB Journal's website.
The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). The world's most cited biology journal according to the Institute for Scientific Information, it has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century. Receive monthly highlights for The FASEB Journal; subscribe at http://www.faseb.org/fjupdate.aspx.
FASEB is composed of 30 societies with more than 130,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to our societies and their members.